UBX - Unity Biotechnology Inc
IEX Last Trade
1.62
-0.040 -2.469%
Share volume: 29,353
Last Updated: Fri 30 Aug 2024 09:49:38 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.66
-0.04
-2.41%
Summary score
9%
Profitability
8%
Dept financing
6%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.43%
Return on assets
-13.08%
Return on sales
0%
Return on invested capital
287.37%
Total debt ratio
16.53%
Debt ratio change over timeo
-1.05%
Current Ratio
11.35%
Quick Ratio
0%
Cash Position Ratio
2.65%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.17%
Return on assets
-15.3%
Return on sales
0%
Return on invested capital
-389.92%
Total debt ratio
25.97%
Debt ratio change over timeo
-1.11%
Current Ratio
8.03%
Quick Ratio
0%
Cash Position Ratio
2.25%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.54%
Return on assets
-13.58%
Return on sales
0%
Return on invested capital
-71.62%
Total debt ratio
31.73%
Debt ratio change over time
-1.32%
Current Ratio
7.88%
Quick Ratio
0%
Cash Position Ratio
2.53%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97%
Return on assets
-97.71%
Return on sales
0%
Return on invested capital
-11.25%
Total debt ratio
-104.95%
Debt ratio change over time
-1.05%
Current Ratio
-2.71%
Quick Ratio
0%
Cash Position Ratio
-1.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UBX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.43% | -3.05% | 11.55% | 6.27% |
| Return on assets | -13.08% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 287.37% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 16.53% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.05% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 8.03% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.25% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 21% | 39% | 43% |
| Short-term ratios | UBX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.17% | -25.62% | 17.94% | 7.14% |
| Return on assets | -15.3% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -389.92% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 25.97% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.11% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 8.03% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.25% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 40% | 30% | 52% |